CADTH recommends medical abortion reimbursement

Statement of Vicki Saporta, President and CEO of the National Abortion Federation Canada on the Canadian Agency for Drugs and Technologies in Health (CADTH) recommendation on Mifegymiso: We are pleased that CADTH has recommended that mifepristone and misoprostol be reimbursed for medical abortion care. CADTH’s recommendation will help make medical abortion care more widely accessible…

Read More